The effect of xerostomia on the quality of life of controlled and uncontrolled type 2 diabetes mellitus patients

Sectio Aprista; Surya Nelis; Avina Anin Nasia; Yoghi Bagus Prabowo

doi:10.24198/pjd.vol35no1.41996

The effect of xerostomia on the quality of life of controlled and uncontrolled type 2 diabetes mellitus patients

Sectio Aprista, Surya Nelis, Avina Anin Nasia, Yoghi Bagus Prabowo

Abstract

ABSTRACT

Introduction: One of type 2 diabetes mellitus oral manifestations is xerostomia. Xerostomia can cause various problems, such as difficulty of eating, chewing and swallowing, so that it can affect the quality of life. The aim of this research is to analyze the effect of xerostomia on the quality of life of controlled and uncontrolled type 2 diabetes mellitus patients. Methods: This analytical observational cross-sectional study involving 92 subjects from type 2 diabetes mellitus patients aged 21 to 50 years (Patients of controlled and uncontrolled type 2 diabetes mellitus 46 subjects each). Xerostomia data was collected by Summated Xerostomia Inventory-Dutch Version questionnaire, while the quality of life data was collected by Xerostomia-related Quality of Life Scale (XeQoLs) questionnaire. All research data were analyzed descriptively and bivariate analysis with Chi-Square test. Results: The results showed that the quality of life of controlled and uncontrolled type 2 diabetes mellitus patients was equally low (50% in controlled type 2 DM patients and 64.9% in uncontrolled type 2 DM patients). This result showed that there is no difference between each subject groups. This also can be seen from the results of statistical tests that p = 0.193 (p>0.05), which means that there is no significant difference between the quality of life of controlled and uncontrolled type 2 diabetes mellitus patients. Conclusion: There was no effect between xerostomia of controlled and uncontrolled type 2 DM patients with their quality of life.

Keywords: type 2 diabetes mellitus, xerostomia-related to quality of life, xerostomia

Keywords

type 2 diabetes mellitus, xerostomia-related to quality of life, xerostomia

Full Text:

PDF

References

REFERENCES

Cicmil S, Mladenović I, Krunić J, Ivanović D, Stojanović N. Oral Alterations in Diabetes Mellitus. Balk J Dent Med. 2018; 22(1): 7–14. DOI: 10.2478/bjdm-2018-0002

Rohani B. Oral Manifestation in Patients with Diabetes Mellitus. World J Diabetes. 2019; 10(9): 485–9. DOI: 10.4239/wjd.v10.i9.485.

American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2015; 38(1): S8–16. DOI: 10.2337/dc15-S005.

Peres LS, Galato D, Medeiros GHF. Relationship of Salivary Flow of Diabetic Patients. RSBO Revista Sul-Brasileira de Odontologia. 2016; 3(2): 91-7.

Poretsky L, editor. Principles of Diabetes Mellitus. 3rd ed. New York: Springers; 2017. DOI: 10.1007/978-3-319-18741-9_11.

Lessa L, Pires P, Ceretta R, Becker I, Ceretta L, Tuon L, et al. Meta-Analysis of Prevalence of Xerostomia in Diabetes Mellitus. Int Arch Med. 2015; 8(224): 1–13. DOI: 10.3823/1823

Pinatih M, Pertiwi N, Wihandani D. Hubungan Karakteristik Pasien Diabetes Melitus dengan Kejadian Xerostomia di RSUP Sanglah Denpasar. Bali Dent J. 2019; 3(2) :79–84. DOI: 10.51559/bdj.v3i2.206.

Glick M. Burket’s Oral Medicine. 12th ed. USA: People’s Medical Publishing House; 2015.

Niklander S, Veas L, Barrera C, Fuentes F, Chiappini G, Marshall M. Risk factors, hyposalivation and impact of xerostomia on oral health-related quality of life. Braz Oral Res. DOI: 10.1590/1807-3107BOR-2017.vol31.0014.

Molania T, Alimohammadi M, Akha O, Mousavi M, Razvini R, Salehi M. The Effect of Xerostomia and Hyposalivation on The Quality of Life of Patient with Type II Diabetes Mellitus. Electron Physician. 2017; 9(11): 5814–9. DOI: 10.19082/5814.

Shrivastava S, Naidu G, Makkad R, Nagi R, Jain S. Oral Health Related Quality of Life of Controlled and Uncontrolled Type II Diabetes Mellitus Patients-A Questionnaire Based Comparative Study. J Dent Oro-facial Res. 2018; 14(2): 20–4.

Kumari M, Patthi B, Janakiram C, Singla A, Malhi R, Rajeev A. Oral Health ‑ Related Quality of Life in Well ‑ Controlled Diabetic Patients of Modinagar City : A Cross ‑ sectional Study. J Indian Assoc Public Heal Dent. 2020; 18(1): 54–9. DOI: 10.4103/jiaphd.jiaphd.

Putten G, Brand H, Schols J, Baat C. The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents. Clin Oral Investig. 2011; 15(2): 185–92. DOI: 10.1007/s00784-010-0382-1.

Bagley A, Ye R, Garden A, Gunn G, Rosenthal D, Fuller C, et al. Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy. Radiother Oncol. 2020; 142: 133–9. DOI: 10.1016/j.radonc.2019.07.012.

Classification of diabetes mellitus. Geneva: World Health Organization; 2019. p7.

Naba OS, Adu AA, Tedju Hinga IA. Gambaran Karakteristik Pasien Diabetes Melitus di Wilayah Kerja Puskesmas Sikumana Kota Kupang. Media Kesehat Masy. 2021; 3(2): 186–94. DOI: 10.35508/mkm.v3i2.3468.

Hutabarat UM, Hasneli Y, Erwin. Hubungan Komplikasi Diabetes Mellitus Dengan Kualitas Hidup Pasien Diabetes Mellitus. J Keperawatan. 2018; 5(2): 459.

Al-Maweri SA, Altayyar MO, Alqahtani KW, Bamasud MS, Alghamdi OY, Ashraf S, et al. Xerostomia, salivary flow, and oral health status among saudi diabetic patients: A comparative cross-sectional study. Clin Cosmet Investig Dent. 2021; 13(October): 451–8. DOI: 10.2147/ccide.s337581

Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2014; 11: 45-51. DOI: 10.2147/TCRM.S76282.

Arany S, Kopycka-Kedzierawski DT, Caprio TV, Watson GE. Anticholinergic medication: Related dry mouth and effects on the salivary glands. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021; 132(6): 662-70. DOI: 10.1016/j.oooo.2021.08.015.

Lee N, Duan H, Hebert M, Liang J, Rice K, Wang J. Taste of a pill: Organic cation transporter-3 (OCT3) mediates metformin accumulation and secretion in salivary glands. J Biol Chem. 2014; 289(39): 27055–64. DOI : 10.1074/jbc.m114.570564

Quaile M, Melich D, Jordan H, Nold J, Chism J, Polli J, et al. Toxicity and toxicokinetics of metformin in rats. Toxicol Appl Pharmacol. 2010; 243(3): 340–7. DOI : 10.1016/j.taap.2009.11.026

Kurniawan AA, Wedhawati MW, Triani M, Imam DNA, Laksitasari A. Laporan Kasus: Xerostomia pada Penderita Diabetes Mellitus Tipe 2. Stomatognatic (JKG Unej). 2020; 17(1): 33–6. DOI: 10.19184/stoma.v17i1.23615

Sari R, Widiajmoko A. Pengaruh Komplikasi Neuropati Terhadap Xerostomia Pada Penderita Diabetes Mellitus Tipe II. Idj. 2012; 1(1): 20–6.

Sadeghi R, Taleghani F, Farhadi S. Oral health related quality of life in diabetic patients. J Dent Res Dent Clin Dent Prospects. 2014; 8(4): 230–4. DOI : 10.5681/joddd.2014.41

Khalifa N, Rahman B, Gaintantzopoulou MD, Al-Amad S, Awad MM. Oral health status and oral health-related quality of life among patients with type 2 diabetes mellitus in the United Arab Emirates: a matched case-control study. Health Qual Life Outcomes. 2020; 18(1): 182. DOI: 10.1186/s12955-020-01418-9.

Agustina D, Purwanti N, Hanindriyo L, Naritasari F. Oral health-related quality of life in type 2 diabetic patients of Yogyakarta General Hospital. 2021; 7(1): 1–9. DOI : 10.22146/majkedgiind.43693.

Poudel P, Griffiths R, Arora A, Wong VW, Flack JR, Barker G, et al. Oral health status, knowledge and behaviours of people with diabetes in Sydney, Australia. Int J Environ Res Public Health. 2021; 18(7): 1–15. DOI: 10.3390%2Fijerph18073464

DOI: https://doi.org/10.24198/pjd.vol35no1.41996